Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
Severe acute respiratory syndrome (SARS) coronavirus infection and growth are dependent on initiating signaling and enzyme actions upon viral entry into the host cell. Proteins packaged during virus assembly may subsequently form the first line of attack and host manipulation upon infection. A complete characterization of virion components is therefore important to understanding the dynamics of early stages of infection. Mass spectrometry and kinase profiling techniques identified nearly 200 incorporated host and viral proteins. We used published interaction data to identify hubs of connectivity with potential significance for virion formation. Surprisingly, the hub with the most potential connections was not the viral M protein but the nonstructural protein 3 (nsp3), which is one of the novel virion components identified by mass spectrometry. Based on new experimental data and a bioinformatics analysis across the Coronaviridae , we propose a higher-resolution functional domain architecture for nsp3 that determines the interaction capacity of this protein. Using recombinant protein domains expressed in Escherichia coli , we identified two additional RNA-binding domains of nsp3. One of these domains is located within the previously described SARS-unique domain, and there is a nucleic acid chaperone-like domain located immediately downstream of the papain-like proteinase domain. We also identified a novel cysteine-coordinated metal ion-binding domain. Analyses of interdomain interactions and provisional functional annotation of the remaining, so-far-uncharacterized domains are presented. Overall, the ensemble of data surveyed here paint a more complete picture of nsp3 as a conserved component of the viral protein processing machinery, which is intimately associated with viral RNA in its role as a virion component.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, proteomics has characterized the infectious CoV-1 viral particle143, temporal changes in host cells during infection142 and virus-induced endoplasmic reticulum membrane remodelling into double-membrane vesicles152,153 that house viral replication compartments146.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [143]
In the citing paper
“Consistently, host vesicular trafficking, translation, RNA splicing, nucleotide synthesis and glycolysis pathway proteins were upregulated following infection143,144 and targeting these processes with inhibitors revealed potential therapeutic targets158,159.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [143]
Citations
Cites
Basic local alignment search tool
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., & Lipman, D. J. (1990) · Journal of Molecular Biology · doi:10.1006/jmbi.1990.9999 · Cited by 98,669 · cited 2×
“using NCBI BLAST (1) to identify homologous regions and then Clustal to align”
MethodKrogh, A., Larsson, B., von Heijne, G., & Sonnhammer, E. L. L. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4315 · Cited by 12,654 · cited 1×
“(30), and structure/loop context from PredictProtein analysis (46).”
BackgroundNetwork biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 1×
“Network analysis (2) based on previously reported biochemical interaction mapping (65) revealed several hubs of connectivity (we use the term “hub of connectivity” or “hub” to refer to molecular species showing an outstandingly large number of intermolecular interactions) among incorporated components of viral origin.”
BackgroundEng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“remaining after filtering were searched with the SEQUEST algorithm (12)”
MethodSelf-citationMultiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875 · cited 1×
“Bioinformatics analysis. An initial multiple sequence alignment was produced using NCBI BLAST (1) to identify homologous regions and then Clustal to align the homologous regions ( 8 ).”
MethodLarge-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,752 · cited 1×
“After desalting, a 100-m-inside-diameter capillary with a 5-m pulled tip packed with 10-cm, 3-m Aqua C18 material was attached to the filter union, and the entire split column was placed in line with an Agilent 1100 quaternary high-pressure liquid chromatograph (Agilent, Palo Alto, CA) and analyzed using a modified 11…”
MethodSelf-citationPoly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
An Automated Multidimensional Protein Identification Technology for Shotgun Proteomics
Wolters, D. A., Washburn, M. P., & Yates, J. R. (2001) · Analytical Chemistry · doi:10.1021/ac010617e · Cited by 1,819 · cited 1×
“The protein digest from each sample was analyzed by Multidimensional Protein Identification Technology (MudPIT) ( 69 ).”
MethodSelf-citationThe Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,761 · cited 1×
“The M protein links the other major virion components at the site of budding (35), and an integral role for the RNA genome in assembly had been anticipated (15).”
BackgroundRost, B., Yachdav, G., & Liu, J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh377 · Cited by 1,453
Research works printed but not linked: 2
- 10.1128/jvi.74.11.4967-4978.2000 · doi:10.1128/jvi.74.11.4967-4978.2000 · Paper page
- 10.1042/bj3420119 · doi:10.1042/bj3420119 · Paper page
Cited by
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Knoops, K., Kikkert, M., Worm, S. H. E. V. D., Zevenhoven-Dobbe, J. C., van der Meer, Y., Koster, A. J., Mommaas, A. M., & Snijder, E. J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060226 · Cited by 1,015
“[23,42], the viral main protease nsp5 [43], and the nsp8”
BackgroundProteomics of SARS-CoV-2-infected host cells reveals therapy targets
Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C. (2020) · Nature · doi:10.1038/s41586-020-2332-7 · Cited by 1,010
Weiss, S. R., & Leibowitz, J. L. (2011) · Advances in Virus Research · doi:10.1016/b978-0-12-385885-6.00009-2 · Cited by 896
A structural analysis of M protein in coronavirus assembly and morphology
Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F., Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., et al. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2010.11.021 · Cited by 841
Self-citationBáez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein
Lei, J., Kusov, Y., & Hilgenfeld, R. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.11.001 · Cited by 727
“Ubl2 and PL2pro are conserved in all CoVs (Neuman et al., 2008; Neuman, 2016).”
BackgroundMethodInfluentialContinuous and Discontinuous RNA Synthesis in Coronaviruses
Sola, I., Almazán, F., Zúñiga, S., & Enjuanes, L. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-055218 · Cited by 643
Host Factors in Coronavirus Replication
de Wilde, A. H., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2017) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2017_25 · Cited by 546
“A role for secretory pathway proteins was also confirmed by a proteomic analysis of purified SARS-CoV virions, which identified, besides several viral proteins including nsp2, nsp3, and nsp5, 172 host proteins in virions (Neuman et al. 2008).”
BackgroundA molecular pore spans the double membrane of the coronavirus replication organelle
Wolff, G., Limpens, R. W. A. L., Zevenhoven-Dobbe, J. C., Laugks, U., Zheng, S., de Jong, A. W. M., Koning, R. I., Agard, D. A., Grünewald, K., Koster, A. J., et al. (2020) · Science · doi:10.1126/science.abd3629 · Cited by 527
Angelini, M. M., Akhlaghpour, M., Neuman, B. W., & Buchmeier, M. J. (2013) · mBio · doi:10.1128/mbio.00524-13 · Cited by 527
“SARS-CoV nsp3 is a 215-kDa, transmembrane, glycosylated, multidomain protein that has been shown to interact with numerous other proteins involved in replication and transcription and, as such, may serve as a scaffolding protein for these processes (45) (46) (47) (48) (49) .”
Self-citationBrown, A. J., Won, J. J., Graham, R. L., Dinnon, K. H., Sims, A. C., Feng, J. Y., Cihlar, T., Denison, M. R., Baric, R. S., & Sheahan, T. P. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104541 · Cited by 510
Pfefferle, S., Schöpf, J., Kögl, M., Friedel, C. C., Müller, M. A., Carbajo-Lozoya, J., Stellberger, T., von Dall’Armi, E., Herzog, P., Kallies, S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002331 · Cited by 415
Serological assays for emerging coronaviruses: Challenges and pitfalls
Meyer, B., Drosten, C., & Müller, M. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.018 · Cited by 410
“In fact, it was shown that some NSPs and accessory ORF-encoded proteins can be incorporated into viral particles (Neuman et al., 2008) and are possibly able to elicit an immune response.”
BackgroundPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
White, K. M., Rosales, R., Yildiz, S., Kehrer, T., Miorin, L., Moreno, E., Jangra, S., Uccellini, M. B., Rathnasinghe, R., Coughlan, L., et al. (2021) · Science · doi:10.1126/science.abf4058 · Cited by 343
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 319
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
Ogando, N. S., Zevenhoven-Dobbe, J. C., van der Meer, Y., Bredenbeek, P. J., Posthuma, C. C., & Snijder, E. J. (2020) · Journal of Virology · doi:10.1128/jvi.01246-20 · Cited by 282
“( SM) domain of nsp3, which has been predicted to be a nonenzymatic domain (64) and is absent in alpha- and deltacoronaviruses (65, 66).”
BackgroundCoronavirus genomic RNA packaging
Masters, P. S. (2019) · Virology · doi:10.1016/j.virol.2019.08.031 · Cited by 261
“Both the RbCoV and the EqCoV partial PS duplications occur at exactly the same site in a highly variable region of the replicase nsp3 subunit, situated between two domains designated NAB and G2M (Neuman et al., 2008) .”
Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A., & Kennedy, R. B. (2020) · Immunological Reviews · doi:10.1111/imr.12897 · Cited by 258
Cannalire, R., Cerchia, C., Beccari, A. R., Di Leva, F. S., & Summa, V. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01140 · Cited by 238
Molecular evolution and emergence of avian gammacoronaviruses
Jackwood, M. W., Hall, D., & Handel, A. (2012) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2012.05.003 · Cited by 227
Macrodomains: Structure, Function, Evolution, and Catalytic Activities
Rack, J. G. M., Perina, D., & Ahel, I. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014935 · Cited by 217
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
Mariano, G., Farthing, R. J., Lale-Farjat, S. L. M., & Bergeron, J. R. C. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.605236 · Cited by 204
High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling
Irigoyen, N., Firth, A. E., Jones, J. D., Chung, B. Y.-W., Siddell, S. G., & Brierley, I. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005473 · Cited by 212
“The nsp3 pausing site is located in the linker region between two modular domains of the protein, i.e. ADRP [108] and the recently identified DPUP [76] , and we hypothesize that the pause may occur after synthesis of the first domain in order to allow it to fold properly before synthesis of the second domain.”
BackgroundCoronaviruses: An Updated Overview of Their Replication and Pathogenesis
Wang, Y., Grunewald, M., & Perlman, S. (2020) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0900-2_1 · Cited by 208
“It contains a hypervariable acidic N-terminal region that is a ubiquitin-like domain (Ubl1) and a highly conserved C-terminal region which is designated the Y domain and contains three metal-binding clusters of cysteine and histidine residues [105].”
BackgroundThe eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
Abbas, W., Kumar, A., & Herbein, G. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00075 · Cited by 203
“SARS-CoV eEF1A found in mature virion (109)”
BackgroundCoronavirus envelope (E) protein remains at the site of assembly
Venkatagopalan, P., Daskalova, S. M., Lopez, L. A., Dolezal, K. A., & Hogue, B. G. (2015) · Virology · doi:10.1016/j.virol.2015.02.005 · Cited by 210
“A large number of host proteins copurify with SARS virions and recently host and viral proteins that interact with E were identified (Alvarez et al., 2010; Neuman et al., 2008; Teoh et al., 2010).”
A high-stringency blueprint of the human proteome
Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210
Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins
Gorkhali, R., Koirala, P., Rijal, S., Mainali, A., Baral, A., & Bhattarai, H. K. (2021) · Bioinformatics and Biology Insights · doi:10.1177/11779322211025876 · Cited by 169
The SARS-Unique Domain (SUD) of SARS Coronavirus Contains Two Macrodomains That Bind G-Quadruplexes
Tan, J., Vonrhein, C., Smart, O. S., Bricogne, G., Bollati, M., Kusov, Y., Hansen, G., Mesters, J. R., Schmidt, C. L., & Hilgenfeld, R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000428 · Cited by 169
“contains at least seven subdomains [2]: An N-terminal acidic”
BackgroundInfluentialHurst, K. R., Koetzner, C. A., & Masters, P. S. (2013) · Journal of Virology · doi:10.1128/jvi.01275-13 · Cited by 167
“Our assignment of the boundaries of the Ubl1 and Ac domains was based on alignment of 269 the nsp3 sequences of numerous betacoronaviruses (45, 46), as well as the available structure of 270 SARS-CoV Ubl1 (27) and in vitro mapping of the upstream limit of MHV PLP1 (35, 38).”
MethodThe nsp3 Macrodomain Promotes Virulence in Mice with Coronavirus-Induced Encephalitis
Fehr, A. R., Athmer, J., Channappanavar, R., Phillips, J. M., Meyerholz, D. K., & Perlman, S. (2015) · Journal of Virology · doi:10.1128/jvi.02596-14 · Cited by 155
RNA-RNA and RNA-protein interactions in coronavirus replication and transcription
Sola, I., Mateos-Gomez, P. A., Almazan, F., Zuñiga, S., & Enjuanes, L. (2011) · RNA Biology · doi:10.4161/rna.8.2.14991 · Cited by 150
Carbajo-Lozoya, J., Ma‐Lauer, Y., Malešević, M., Theuerkorn, M., Kahlert, V., Prell, E., von Brunn, B., Muth, D., Baumert, T. F., Drosten, C., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.02.010 · Cited by 146
“A rabbit anti-Lami eported to bind to CypA (Luo et al., 2004) and CypA is incorporated nto SARS-CoV particles (Neuman et al., 2008) the inhibitors might lso act directly on CypA/N-protein complexes, if these also exist in CoV-NL63.”
BackgroundLi, D., Wei, T., Abbott, C. M., & Harrich, D. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00059-12 · Cited by 158
Supramolecular Architecture of the Coronavirus Particle
Neuman, B. W., & Buchmeier, M. J. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.005 · Cited by 149
Self-citationThe Footprint of Genome Architecture in the Largest Genome Expansion in RNA Viruses
Lauber, C., Goeman, J. J., Parquet, M. D. C., Nga, P. T., Snijder, E. J., Morita, K., & Gorbalenya, A. E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003500 · Cited by 149
Hurst, K. R., Ye, R., Goebel, S. J., Jayaraman, P., & Masters, P. S. (2010) · Journal of Virology · doi:10.1128/jvi.01287-10 · Cited by 130
Báez-Santos, Y. M., Mielech, A. M., Deng, X., Baker, S., & Mesecar, A. D. (2014) · Journal of Virology · doi:10.1128/jvi.01294-14 · Cited by 128
Kusov, Y., Tan, J., Alvarez, E., Enjuanes, L., & Hilgenfeld, R. (2015) · Virology · doi:10.1016/j.virol.2015.06.016 · Cited by 122
A Comprehensive Review About SARS-CoV-2
Haque, S. M., Ashwaq, O., Sarief, A., & Azad John Mohamed, A. K. (2020) · Future Virology · doi:10.2217/fvl-2020-0124 · Cited by 121
Mechanisms of Severe Acute Respiratory Syndrome Pathogenesis and Innate Immunomodulation
Frieman, M., & Baric, R. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00015-08 · Cited by 107
SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology
Morales, L., Oliveros, J. C., Fernández‐Delgado, R., tenOever, B. R., Enjuanes, L., & Sola, I. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.01.015 · Cited by 115
Kuri, T., Eriksson, K. K., Putics, A., Züst, R., Snijder, E. J., Davidson, A. D., Siddell, S. G., Thiel, V., Ziebuhr, J., & Weber, F. (2011) · Journal of General Virology · doi:10.1099/vir.0.031856-0 · Cited by 101
Chandramouli, S., Joseph, J. S., Daudenarde, S., Gatchalian, J., Cornillez-Ty, C. T., & Kühn, P. (2009) · Journal of Virology · doi:10.1128/jvi.02044-09 · Cited by 102
Self-citationNeuman, B. W. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.005 · Cited by 98
“SARS-CoV nsp3-nsp3 interactions have been detected in cells by yeast two-hybridization (Pan et al., 2008) and GST pulldown (Imbert et al., 2008), and in purified protein by perfluorooctanoic acid polyacrylamide gel electrophoresis (Neuman et al., 2008).”
InfluentialSelf-citationRecent Developments in Anti-Severe Acute Respiratory Syndrome Coronavirus Chemotherapy
Barnard, D. L., & Kumaki, Y. (2011) · Future Virology · doi:10.2217/fvl.11.33 · Cited by 98
“The SARS‐CoV papain‐like protease carries out N‐terminal processing of the viral replicase polyprotein [34], catalyzes Lys48‐ linked polyubiquitin chain debranching [35] and appears to process fusion proteins of the ubiquitin‐like modifier ISG15, encoded by an interferon‐stimulated gene in vitro [33].”
BackgroundHossain, A., Akter, S., Rashid, A. A., Khair, S., & Alam, A. S. M. R. U. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105699 · Cited by 98
Analysis of non-structural proteins, NSPs of SARS-CoV-2 as targets for computational drug designing
Raj, R. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100847 · Cited by 85
“The structure of NSP 3 shows the presence of RNA-binding domains [6], SARS Unique Domain, SUD [7] which in turn has three sub domains, N-terminal, Middle and C-terminal domains [8] and papain like protease, PL-PRO domain to achieve full activity of the protein [9].”
Serrano, P., Johnson, M. A., Chatterjee, A., Neuman, B. W., Joseph, J. S., Buchmeier, M. J., Kühn, P., & Wüthrich, K. (2009) · Journal of Virology · doi:10.1128/jvi.01253-09 · Cited by 84
Self-citationKumar, R., Verma, H., Singhvi, N., Sood, U., Gupta, V., Singh, M., KUMARI, R. R., Hira, P., Nagar, S., Talwar, C., et al. (2020) · mSystems · doi:10.1128/msystems.00505-20 · Cited by 84
“Although previous studies showed that the role of interactions between spliceosome components and host proteins was substantial in SARS-CoV infections and other coronavirus infections (43, 44), with this study, we confirmed their role in novel coronavirus (SARS-CoV-2) infection, too.”
ResultMa‐Lauer, Y., Zheng, Y., Malešević, M., von Brunn, B., Fischer, G., & von Brunn, A. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104620 · Cited by 81
“This was supported by a spectrometric profiling study showing the incorporation of CypA into SARS-CoV virions (Neuman et al., 2008).”
Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
Joshi, A., Joshi, B. C., Mannan, M. A.-U., & Kaushik, V. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100338 · Cited by 80
“Both of these proteins may influence in viral pathogenesis and disease spread, although the literature lacks unanimity [43].”
BackgroundCyclophilins and cyclophilin inhibitors in nidovirus replication
de Wilde, A. H., Pham, U., Posthuma, C. C., & Snijder, E. J. (2018) · Virology · doi:10.1016/j.virol.2018.06.011 · Cited by 76
“Using a mass-spectrometrybased approach, Neuman et al. (2008) confirmed the presence of CypA in SARS-CoV virions, although no function was proposed for virionassociated CypA.”
BackgroundMethodKappes, M. A., Miller, C. L., & Faaberg, K. S. (2013) · Journal of Virology · doi:10.1128/jvi.02435-13 · Cited by 76
Drug repurposing for new, efficient, broad spectrum antivirals
García‐Serradilla, M., Risco, C., & Pacheco, B. (2019) · Virus Research · doi:10.1016/j.virusres.2019.02.011 · Cited by 75
de Wilde, A. H., Wannee, K. F., Scholte, F. E. M., Goeman, J. J., ten Dijke, P., Snijder, E. J., Kikkert, M., & van Hemert, M. J. (2015) · Journal of Virology · doi:10.1128/jvi.01029-15 · Cited by 74
Lavigne, M., Helynck, O., Rigolet, P., Boudria-Souilah, R., Nowakowski, M., Baron, B., Brülé, S., Hoos, S., Raynal, B., Guittat, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab571 · Cited by 71
Innate immune evasion by SARS‐CoV ‐2: Comparison with SARS‐CoV
Bouayad, A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2135 · Cited by 75
“Nsp3 is a NS protein of SARS-CoV-2 that contains several domains.(75) Specifically, engaged SARS-CoV-2 unique domain (SUD) M and C of Nsp3c activates NLRP3 inflammasome signaling responses”
BackgroundAtlas of coronavirus replicase structure
Neuman, B. W., Chamberlain, P., Bowden, F., & Joseph, J. S. (2013) · Virus Research · doi:10.1016/j.virusres.2013.12.004 · Cited by 71
“Structure and function The membrane topology of nsp6 has been determined (Oostra et al., 2008).”
Self-citationChang, Y.-S., Ko, B.-H., Ju, J.-C., Chang, H., Huang, S., & Lin, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093179 · Cited by 64
“, An N-terminal Glu-rich acidic domain (also called Nsp3a), an X domain with poly(ADP-ribose) binding properties (Nsp3b), the SARS-CoV unique domain (SUD) (Nsp3c), papain-like protease (PL2pro, Nsp3d), non-canonical papain-like domain, and a Y domain (Nsp3e) [16].”
BackgroundGarvin, M. R., Prates, E. T., Pavicic, M., Jones, P. C., Amos, B. K., Geiger, A., Shah, M. B., Streich, J., Gazolla, J. G. F. M., Kainer, D., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02191-0 · Cited by 66
“Electrophoretic mobility shift assays may be effective to test this hypothesis [67].”
BackgroundSARS Coronavirus Unique Domain: Three-Domain Molecular Architecture in Solution and RNA Binding
Johnson, M. A., Chatterjee, A., Neuman, B. W., & Wüthrich, K. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.027 · Cited by 63
Self-citationRole of RNA chaperones in virus replication
Zúñiga, S., Sola, I., Cruz, J. L. G., & Enjuanes, L. (2008) · Virus Research · doi:10.1016/j.virusres.2008.06.015 · Cited by 66
“It is worth noting that the number of coronavirus-encoded RNA chaperones could grow with the addition of some non-structural proteins, such as SARS-CoV nsp3 (Neuman et al., 2008) .”
BackgroundIslam, M. J., Islam, N. N., Alom, M. S., Kabir, M., & Halim, M. A. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152302 · Cited by 69
Lee, S.-H., & Lee, C. (2015) · Virus Research · doi:10.1016/j.virusres.2015.06.013 · Cited by 62
“responses to viral infection or viral protein expression and to gain specific insights into the cellular mechanisms involved in viral pathogenesis (Alfonso et al., 2004; Brasier et al., 2004; Neuman et al., 2008; Oh and Lee, 2012; Ringrose et al., 2008; Sagong and Lee, 2010; Zhang et al., 2008) .”
BackgroundÁlvarez, E. A., DeDiego, M. L., Nieto-Torres, J. L., Jiménez-Guardeño, J. M., Marcos-Villar, L., & Enjuanes, L. (2010) · Virology · doi:10.1016/j.virol.2010.03.015 · Cited by 57
“Interestingly, a recent report identifying the SARS-CoV structural proteins showed that, in addition to the well know structural proteins S, E, M, and N, nsp3 is a tentative novel minor virion component (Neuman et al., 2008).”
Chatterjee, A., Johnson, M. A., Serrano, P., Pedrini, B., Joseph, J. S., Neuman, B. W., Saikatendu, K. S., Buchmeier, M. J., Kühn, P., & Wüthrich, K. (2008) · Journal of Virology · doi:10.1128/jvi.01781-08 · Cited by 56
“This sequence segment has less than 30% amino acid identity with known proteins, except for the corresponding polypeptide segments in SARS-like and HKU3-like bat coronaviruses ( 27 ), which have more than 90% sequence identity but for which no 3D structures have as yet been determined.”
BackgroundMethodSelf-citationMoerdyk-Schauwecker, M. J., Hwang, S., & Grdzelishvili, V. Z. (2009) · Virology Journal · doi:10.1186/1743-422x-6-166 · Cited by 55
Altincekic, N., Korn, S. M., Qureshi, N. S., Dujardin, M., Ninot‐Pedrosa, M., Abele, R., Saad, M. J. A., Alfano, C., Almeida, F. C. L., Alshamleh, I., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.653148 · Cited by 57
Cho, C., Lin, M.-H., Chuang, C.-Y., & Hsu, C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700542 · Cited by 55
“In SARS-CoV, the largest NSP member, NSP3, is a multidomain protein containing the following domains: N-terminal acidic domain, macro domain, SARS-unique domain, PL pro , nucleic acid-binding domain, marker domain (G 2 M), transmembrane domain, and Y-domain (17) .”
BackgroundRoth-Cross, J. K., Stokes, H., Chang, G., Chua, M. M., Thiel, V., Weiss, S. R., Gorbalenya, A. E., & Siddell, S. G. (2009) · Journal of Virology · doi:10.1128/jvi.02203-08 · Cited by 50
“... with the additional potential to modify cellular proteins by deubiquitination, domains such as the poly(ADP-ribose)-binding domain (also known as ADP ribose 1-phosphatase, ADRP, or X domain) with as-yet-undefined roles in the virus life cycle, and “orphan” domains such as the SARS-CoV-unique domain and other simil…”
BackgroundAn overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies
Farooqi, T., Malik, J. A., Mulla, A. H., Hagbani, T. A., Almansour, K., Ubaid, M. A., Alghamdi, S., & Anwar, S. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.08.014 · Cited by 51
Virus–host interactomes — antiviral drug discovery
Ma‐Lauer, Y., Lei, J., Hilgenfeld, R., & von Brunn, A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.003 · Cited by 53
Practical application of bioinformatics by the multidisciplinary VIZIER consortium
Gorbalenya, A. E., Lieutaud, P., Harris, M. R., Coutard, B., Canard, B., Kleywegt, G. J., Kravchenko, A. A., Samborskiy, D. V., Sidorov, I. A., Leontovich, A. M., et al. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.02.005 · Cited by 47
“Also a large number of poorly characterized domains that were recognized as unique for phylogenetically compact groups of viruses, e.g. group 2a of coronaviruses (g2aUD) (Gorbalenya, unpublished observations; Snijder et al., 2003; Neuman et al., 2008) , were predicted.”
BackgroundUtility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
Sperk, M., van Domselaar, R., Murillo, J. R., Mikaeloff, F., Vinhas, B. S., Saccon, E., Sönnerborg, A. B., Singh, K. D., Gupta, S., Végvári, Á., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00380 · Cited by 50
Chen, Y., Savinov, S. N., Mielech, A. M., Cao, T., Baker, S. C., & Mesecar, A. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662130 · Cited by 48
Cyclophilin A: a key player for etiological agent infection
Liao, Y., Luo, D., Peng, K., & Zeng, Y. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11115-2 · Cited by 43
Taha, T. Y., Suryawanshi, R. K., Chen, I. P., Correy, G. J., McCavitt-Malvido, M., O’Leary, P. C., Jogalekar, M. P., Diolaiti, M. E., Kimmerly, G. R., Tsou, C.-L., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011614 · Cited by 46
“While Mac2 and Mac3 are catalytically inactive, Mac1 can bind ADP-ribosylated protein sidechains and catalyze the hydrolysis of these posttranslational marks for a diverse set of protein targets [10,12–14].”
BackgroundVogels, M. W., van Balkom, B. W. M., Kaloyanova, D. V., Batenburg, J. J., Heck, A. J., Helms, J. B., Rottier, P. J. M., & de Haan, C. A. M. (2011) · PROTEOMICS · doi:10.1002/pmic.201000309 · Cited by 40
“We hypothesize that upon infection with MHV, the ribosomal/ nucleic acid-binding proteins are specifically recruited to the virion assembly sites, possibly by their interaction with viral genomic RNA, resulting in their enrichment in the isolated fractions (this study) and their incorporation into progeny virus [52] .”
Backgroundvon Brunn, A., Ciesek, S., von Brunn, B., & Carbajo-Lozoya, J. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.08.004 · Cited by 40
“This finding was supported by a proteomics study which identified CypA as one of a number of cellular proteins incorporated into purified SARS-CoV particles by spectrometric profiling [38].”
ResultPositive selection as a key player for SARS-CoV-2 pathogenicity: Insights into ORF1ab, S and E genes
Emam, M., Oweda, M., Antunes, A., & El-Hadidi, M. S. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198472 · Cited by 53
“The gene that codes the SARS-CoV domain βSM could not be expressed in E-coli, suggesting that βSM is a non-enzymatic domain (Neuman et al., 2008).”
Zhou, H., Ferraro, D. M., Zhao, J., Hussain, S., Shao, J., Trujillo, J., Netland, J., Gallagher, T. M., & Perlman, S. M. (2010) · Journal of Virology · doi:10.1128/jvi.02570-09 · Cited by 39
Does form meet function in the coronavirus replicative organelle?
Neuman, B. W., Angelini, M. M., & Buchmeier, M. J. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.06.003 · Cited by 39
“Nidovirus proteins encoded in the same genomic position as SARS-CoV nsp3 have several hallmarks -most include a papain-related cysteine proteinase, hydrophobic regions flanking a cysteine-histidine cluster, and one or more RNA-binding macrodomains [25] .”
Self-citationTatlow, D., Tatlow, C., Tatlow, S., & Tatlow, S. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13393 · Cited by 37
Al-Motawa, M., Abbas, H., Wijten, P., de la Fuente, A., Xue, M., Rabbani, N., & Thornalley, P. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585408 · Cited by 43
Phillips, J. E., Jackwood, M. W., McKinley, E. T., Thor, S. W., Hilt, D. A., Acevedol, N. D., Williams, S. M., Kissinger, J. C., Paterson, A. H., Robertson, J. S., et al. (2011) · Virus Genes · doi:10.1007/s11262-011-0668-7 · Cited by 37
Spatial and temporal roles of SARS‐CoV PL pro —A snapshot
Yan, S., & Wu, G. (2020) · The FASEB Journal · doi:10.1096/fj.202002271 · Cited by 45
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Prates-Syed, W. A., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A. A. D. L., Côrtes, N., Kersten, V., Guimarães, F. E. G., Sadraeian, M., da Silva, F. L. B., et al. (2021) · Vaccines · doi:10.3390/vaccines9121409 · Cited by 39
SARS‐CoV ‐2 biology and variants: anticipation of viral evolution and what needs to be done
Luo, R., Delaunay, A., Timmis, K. N., & Danchin, A. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15487 · Cited by 40
“…future respiratory diseases epidemics the construction of habitation, restaurants and office buildings as well as public transport should be submitted to compulsory regulation imposing specific rules on the control of air flow, such as those in surgery theatres (Timmis, 2020; Newsom et al., 2021).”
BackgroundDetection and characterization of diverse alpha- and betacoronaviruses from bats in China
Xu, L., Zhang, F., Yang, W., Jiang, T., Lu, G., He, B., Li, X., Hu, T., Chen, G., Feng, Y., et al. (2016) · Virologica Sinica · doi:10.1007/s12250-016-3727-3 · Cited by 34
“It is proved that two proteinases, papain-like proteinase (PLPro) encoded by nsp3 gene and main proteinase (MPro) encoded by nsp5 gene in ORF1a of CoVs are able to cleave the complex of ORF1a and ORF1b (replicase) into 16 mature nonstructural proteins (nsps) (Neuman et al, 2008).”
BackgroundLiang, J. Q., Fang, S., Yuan, Q., Huang, M., Chen, R., Fung, T. S., & Liu, D. X. (2019) · Virology · doi:10.1016/j.virol.2019.02.017 · Cited by 34
Gupta, A., Kumar, S., Kumar, R., Choudhary, A. K., Kumari, K., Singh, P., & Kumar, V. (2020) · ChemistrySelect · doi:10.1002/slct.202001709 · Cited by 39
Gupta, V., Haider, S., Verma, M., Singhvi, N., Ponnusamy, K., Malik, M. Z., Verma, H., Kumar, R., Sood, U., Hira, P., et al. (2021) · mSystems · doi:10.1128/msystems.00030-21 · Cited by 34
“The presence of myosin protein played a crucial role in coronavirus assembly and budding in the infected cells (33).”
BackgroundNsp3-N interactions are critical for SARS-CoV-2 fitness and virulence
Li, P., Xue, B., Schnicker, N., Wong, L.-Y. R., Meyerholz, D. K., & Perlman, S. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305674120 · Cited by 40
Aldea, M. D., Michot, J., Danlos, F., Ribas, A., & Soria, J. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0144 · Cited by 36
Endomembrane remodeling in SARS-CoV-2 infection
Chen, D., Zhao, Y. G., & Zhang, H. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100031 · Cited by 35
NMR Structure of the SARS-CoV Nonstructural Protein 7 in Solution at pH 6.5
Johnson, M. A., Jaudzems, K., & Wüthrich, K. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.043 · Cited by 32
Self-citation
Metadata
- Authors
- Neuman, B. W., Joseph, J. S., Saikatendu, K. S., Serrano, P., Chatterjee, A., Johnson, M. A., Liao, L., Klaus, J. P., Yates, J. R., Wüthrich, K., Stevens, R. C., Buchmeier, M. J., & Kuhn, P.
- Affiliations
- University of Reading (GB)
- Department of Cell Biology
- Department of Molecular Biology
- Molecular and Integrative Neurosciences Department
- Corresponding author
- Buchmeier, Michael J.
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-06
- Volume
- 82
- Issue
- 11
- Pages
- 5279-5294
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2395186
- OpenAlex
- W2086636612
- Cited by
- 192
- References
- 76
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 2 · 2023: 14 · 2022: 13 · 2021: 26 · 2020: 36 · 2019: 10 · 2018: 1 · 2017: 6 · 2016: 7 · 2015: 13 · 2014: 14 · 2013: 7 · 2012: 2
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Thailand Science Research and Innovation
- National Institutes of Health
- U.S. Public Health Service (HHSN-266200400058C)
- Canadian Institutes of Health Research
- National Institute of General Medical Sciences (U54GM074898)
- National Institute of Allergy and Infectious Diseases (R01AI059799, AI-59799, NIH P41)
- National Institute of Dental and Craniofacial Research (U01DE016267)
- National Center for Research Resources (P41RR011823)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- SARS coronavirus, NSP3, viral assembly, host-virus protein interaction, protein domain architecture, RNA-binding domain, protein-protein interaction network, Coronaviridae
- MeSH terms
- Animals, Chlorocebus aethiops, Cobalt, Nucleic Acids, Phylogeny, Protein Binding, Protein Kinases, Recombinant Proteins, Sensitivity and Specificity, Vero Cells, Virion, Viral Nonstructural Proteins, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.